Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
RKDA 
Arcadia Biosciences Inc (RKDA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/04/2025: RKDA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -59.96% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/04/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 3.73M USD | Price to earnings Ratio - | 1Y Target Price 12 |
Price to earnings Ratio - | 1Y Target Price 12 | ||
Volume (30-day avg) 4323 | Beta 0.78 | 52 Weeks Range 1.85 - 6.44 | Updated Date 04/5/2025 |
52 Weeks Range 1.85 - 6.44 | Updated Date 04/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.17 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-03-26 | When Before Market | Estimate -0.89 | Actual -2.99 |
Profitability
Profit Margin -139.5% | Operating Margin (TTM) -174.75% |
Management Effectiveness
Return on Assets (TTM) -28.06% | Return on Equity (TTM) -45.62% |
Valuation
Trailing PE - | Forward PE 36.63 | Enterprise Value -360714 | Price to Sales(TTM) 0.74 |
Enterprise Value -360714 | Price to Sales(TTM) 0.74 | ||
Enterprise Value to Revenue 0.08 | Enterprise Value to EBITDA 0.62 | Shares Outstanding 1364940 | Shares Floating 1355830 |
Shares Outstanding 1364940 | Shares Floating 1355830 | ||
Percent Insiders 0.82 | Percent Institutions 10.73 |
Analyst Ratings
Rating 4.5 | Target Price 9 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Arcadia Biosciences Inc
Company Overview
History and Background
Arcadia Biosciences, Inc. was founded in 2004. The company focuses on developing and marketing crop traits and products aimed at enhancing agricultural productivity and human health. Initially, the company focused on trait development, but has shifted to a more product-focused approach.
Core Business Areas
- GoodWheat: Arcadia's GoodWheat portfolio includes wheat varieties with enhanced fiber, reduced gluten, and other nutritional benefits. This segment focuses on improving wheat's nutritional profile for consumers.
- Good Hemp: This business segment focuses on developing and commercializing hemp genetics with improved agronomic traits and cannabinoid profiles. It aims to create value for farmers and consumers in the hemp market.
- Arcadia Specialty Genomics: This segment provides advanced research services to other crop companies.
Leadership and Structure
Arcadia Biosciences is led by a management team with expertise in agriculture, plant science, and business development. The organizational structure includes departments for research and development, commercial operations, and finance.
Top Products and Market Share
Key Offerings
- GoodHemp Seed: Sold to farmers and growers. Competitors include many local hemp seed companies.
- GoodWheat Flour: Sold directly to consumers and through food processing companies. The competitors include King Arthur and other flour producers. Revenue is estimated at under $5 million annually.
- GoodWheat Pasta: A pasta product that contains higher fiber and lower gluten content that typical pasta brands. The competitors include Banza and other high-fiber pasta brands. Revenue is estimated at under $5 million annually.
Market Dynamics
Industry Overview
The agricultural biotechnology industry is driven by the need for increased crop yields, enhanced nutritional content, and sustainable farming practices. The hemp industry is new and fast growing.
Positioning
Arcadia Biosciences positions itself as an innovator in crop improvement, focusing on traits that benefit both farmers and consumers. Its competitive advantage lies in its proprietary technologies and focus on niche markets like enhanced wheat and hemp.
Total Addressable Market (TAM)
The total addressable market for improved wheat and hemp products is estimated to be billions of dollars. Arcadia's market share is small, but is positioned for potential growth.
Upturn SWOT Analysis
Strengths
- Proprietary technology platform
- Focus on high-value traits
- Partnerships with industry leaders
- Strong intellectual property portfolio
Weaknesses
- Limited financial resources
- Dependence on regulatory approvals
- Limited commercialization experience
- Small market share
Opportunities
- Growing demand for healthier food options
- Expansion of the hemp market
- Increasing adoption of sustainable agriculture practices
- Potential for new partnerships and collaborations
Threats
- Competition from larger agricultural companies
- Changing consumer preferences
- Regulatory hurdles
- Economic downturn
Competitors and Market Share
Key Competitors
- KRYS
- BMRA
- LBPS
Competitive Landscape
Arcadia Biosciences faces competition from larger agricultural companies with greater resources. Its advantage lies in its focus on niche markets and its proprietary technology.
Major Acquisitions
Legacy Ventures
- Year: 2022
- Acquisition Price (USD millions): 4
- Strategic Rationale: Expanded hemp seed portfolio and distribution network.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been slow, marked by limited revenue and consistent losses.
Future Projections: Analyst estimates suggest potential for future revenue growth as the company commercializes its products more effectively. However, profitability is not expected in the near term.
Recent Initiatives: Recent initiatives include expanding the GoodWheat portfolio and forming partnerships to commercialize its products.
Summary
Arcadia Biosciences is a small agricultural biotechnology company focusing on niche markets like enhanced wheat and hemp. Its strengths lie in its proprietary technology and focus on high-value traits. However, the company faces financial challenges and competition from larger players. The company is still in early growth stages and needs successful product commercialization to become profitable.
Similar Companies
BMRA
Biomerica Inc
BMRA
Biomerica Inc
KRYS
Krystal Biotech Inc
KRYS
Krystal Biotech Inc
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Analyst reports
- Press releases
- Company website
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Market share estimates are approximate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Arcadia Biosciences Inc
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 2015-05-15 | CEO, President & Director Mr. Thomas J. Schaefer C.F.A. | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 9 | Website https://www.arcadiabio.com |
Full time employees 9 | Website https://www.arcadiabio.com | ||
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.